
Article Fingerprint
ReserarchID
MRLADA8
Choose where you want to hide AI Takeaway. Your site-wide choice will be remembered in this browser.
TTP is a very uncommon disease which used to have very high mortality and morbidity before the introduction of plasmapharesis and immunosup-pressant therapy. Even after the introduction of these modalities, atypical HUS patients had a very grave prognosis and ultimately led to death in many until the introduction of complement inhibitors like eculizumab which is C5a monoclonal antibody. Additionally differentiating typical HUS versus atypical HUS was very difficult but some work on complement markers can be very fruitful in differentiating them.
AliRaza Ghani. 2014. "Latest Diagnostic and Treatment Modalities for TTP". Global Journal of Medical Research - F: Diseases GJMR-F Volume 14 (GJMR Volume 14 Issue F3).
Crossref Journal DOI 10.17406/gjmr
Print ISSN 0975-5888
e-ISSN 2249-4618
v1.2
Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.
Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.
Total Score: 172
Country: United States
Subject: Global Journal of Medical Research
Authors: AliRaza Ghani, Ahsan Raza (PhD/Dr. count: 0)
View Count (all-time): 330
Total Views (Real + Logic): 2003
Total Downloads (simulated): 86
Publish Date: 2014 01, Wed
Monthly Totals (Real + Logic):
We use cookies and similar technologies to improve site performance, understand traffic, and enhance your publishing experience. Cookie Policy
Choose which optional cookies Global Journals can use. Your preference applies across this platform and can be updated any time.
These cookies are required for core website functionality and security.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.